These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33765029)

  • 21. Risk of seizure associated with use of acid-suppressive drugs: An observational cohort study.
    Sáez ME; González-Pérez A; Gaist D; Johansson S; Nagy P; García Rodríguez LA
    Epilepsy Behav; 2016 Sep; 62():72-80. PubMed ID: 27450309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of spontaneous bacterial peritonitis associated with gastric Acid suppression.
    Chang SS; Lai CC; Lee MG; Lee YC; Tsai YW; Hsu WT; Lee CC
    Medicine (Baltimore); 2015 Jun; 94(22):e944. PubMed ID: 26039135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
    Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal and Infant Exposure to Acid-Suppressive Medications and Risk of Allergic Diseases in Children.
    Noh Y; Jeong HE; Choi A; Choi EY; Pasternak B; Nordeng H; Bliddal M; Man KKC; Wong ICK; Yon DK; Shin JY
    JAMA Pediatr; 2023 Mar; 177(3):267-277. PubMed ID: 36622684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
    Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
    Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
    Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
    Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H
    Khawaja M; Thakker J; Kherallah R; Kitakaze M; Jneid H; Angiolillo DJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2024 Feb; 38(1):181-189. PubMed ID: 35715526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013.
    Park SK; Baek YH; Pratt N; Kalisch Ellett L; Shin JY
    Drug Saf; 2018 Jun; 41(6):615-624. PubMed ID: 29397553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.
    Bajaj JS; Ratliff SM; Heuman DM; Lapane KL
    Aliment Pharmacol Ther; 2012 Nov; 36(9):866-74. PubMed ID: 22966967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
    Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
    J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
    Chan J; Hui RL; Szpakowski JL
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study.
    Hsu WH; Kuo CH; Wang SS; Lu CY; Liu CJ; Chuah SK; Kuo FC; Chen YH; Huang YB; Hou MF; Wu DC; Hu HM
    BMC Gastroenterol; 2014 May; 14():91. PubMed ID: 24884853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.
    Lam JR; Schneider JL; Quesenberry CP; Corley DA
    Gastroenterology; 2017 Mar; 152(4):821-829.e1. PubMed ID: 27890768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
    Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock.
    Barletta JF
    Ann Pharmacother; 2014 Oct; 48(10):1276-81. PubMed ID: 24982312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
    Abrahami D; McDonald EG; Schnitzer ME; Barkun AN; Suissa S; Azoulay L
    Gut; 2022 Jan; 71(1):16-24. PubMed ID: 34226290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case-control study.
    Miyano S; Michihata N; Sada KE; Uda K; Matsui H; Fushimi K; Nangaku M; Yasunaga H
    Rheumatology (Oxford); 2021 Apr; 60(4):1717-1723. PubMed ID: 33067623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.